基本信息
浏览量:132
职业迁徙
个人简介
Dr. Giuseppe Bianchi, MD, PhD Pharmacology has been Chief Scientific Officer of CVie Therapeutics Company Limited since October 12, 2012. Dr. Bianchi's research focuses is cardiovascular and renal pathology and pharmacology using genetic approaches. Dr. Bianchi served as the Chief Scientific Officer of Lee's Pharmaceutical Holdings Ltd. since October 12, 2012. In collaboration with a large group of experts both in Milan and abroad, he has studied both patients and animal models with a variety of disciplines (clinical medicine, pathophysiology, epidemiology, cellular and molecular biology and genetics). Dr. Bianchi has devoted most of his professional life in understanding the underling genetic triggering mechanism of hypertension. He is also Professor Emeritus at the "Vita Salute" S. Raffaele University, and Scientific Director of the Prassis Sigma-Tau cardiovascular research institute. He is present and past member of the Editorial Boards of 12 international journals and invited speaker or chairman at more than 500 national and international meetings. He has published more than 300 articles in peer-review journals including high impact journals such as Nature, Science Trans. Med., New England Journal of Medicine and Lancet and more than 200 chapters or reviews in books. Over the years, Prof. Bianchi has combined his academic and clinical experience with parallel work in collaboration with pharmaceutical companies (Lepetit S.p.A., Farmitalia Carlo Erba, and Sigma-Tau S.p.A.) in order to develop a targeted therapeutic approach to cardiovascular diseases through laboratory and in clinical practice.
研究兴趣
论文共 400 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Authorea (Authorea)no. 1 (2024): 1-13
BRITISH JOURNAL OF PHARMACOLOGY (2023): 97-98
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn